Thursday, August 13, 2020

WuXi AppTec Appoints Dr. Frederick H. Hausheer as Chief Medical Officer

SHANGHAI and AUSTIN, Texas, April 8, 2019 -- WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announces the appointment of Dr. Frederick H. Hausheer as Chief Medical Officer for the company. In this executive role, Dr. Hausheer...

WuXi and TruTag Technology Advances Edible On-Dose Authentication Solution for Pharmaceuticals

We are excited to share with you that together with our partner, TruTag Technology, we have successfully completed the joint testing of TruTag’s edible on-dose authentication solution.   TruTags offer a unique solution for drug manufacturers, allowing a digital scan of a drug to confirm...

WuXi AppTec Appoints Dr. David Chang as CEO of WuXi Advanced Therapies Business Unit

SHANGHAI and PHILADELPHIA, June 1, 2020 -- WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announced today the appointment of Dr. David Chang as Chief Executive Officer of WuXi Advanced Therapies business unit (WuXi ATU), WuXi AppTec’s cell and...

WuXi Plans $120 Million Investment in New Integrated Biologics Solution Center to Expedite Biologics Development from Ideas to Clinic

We are excited to announce that we have started construction of a state-of-the-art integrated biologics solution center at our headquarters in Shanghai.  WuXi plans to invest a total of $120 million in this dedicated, 250,000-square-foot facility, which will accommodate 800 scientists.  The facility will...

WuXi AppTec Receives Inaugural “Company of the Year” Award from BayHelix

We are honored to announce that WuXi has received the inaugural “Company of the Year” Award from BayHelix. The award is part of the BayHelix China Healthcare Awards series, celebrating outstanding individuals and companies for their achievement and contribution to the China healthcare ecosystem....

Subscribe to our Newsletter

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS